Effect of age and gender on the pharmacokinetics of R667, a novel agent for the treatment of emphysema, in healthy volunteers

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 10, Issue 1, 2007, Pages 9-16

  Brennan, Barbara ^a,c   Chiu, Y ^a   Berthelon, L ^b   Kolis, S ^a   Davies, B ^a  

^a HOFFMANN LA ROCHE INC   (United States)

^b Institut de Pharmacologie Clinique Roche   (France)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; ESTRADIOL; NORETHISTERONE; PROGESTERONE; R 667; RESPIRATORY TRACT AGENT; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; AREA UNDER THE CURVE; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG POTENTIATION; DRUG SAFETY; DRUG STRUCTURE; FEMALE; HERPES ZOSTER; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; LUNG EMPHYSEMA; MALE; MYALGIA; NORMAL HUMAN; OPEN STUDY; PARALLEL DESIGN; SEX DIFFERENCE; SINGLE DRUG DOSE; TOOTH PAIN;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AREA UNDER CURVE; CYTOCHROME P-450 ENZYME SYSTEM; EMPHYSEMA; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PYRAZOLES; SEX FACTORS;

EID: 34247490124     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Barnes P. New treatments for chronic obstructive pulmonary disease. Ann Ist Super Sanita 2003;39:573-582.
2. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR 2002; 51: 1-16.
3. Snider GL, Kleinerman J, et al. The definition of emphysema: a report of a National Heart, Lung and Blood Institute, Division of Lung Diseases workshop. Am Rev Respir Dis 1985; 132: 182-185.
4. Liu, Cheung P, Mau C, et al. In vitro biotransformation of R667 in humans: identification of isoforms of cytochrome P-450 responsible for metabolism and inhibition kinetics of ketoconazole, midazolam, and erythromycin in human hepatic micosomes. 11th North American ISSX meeting, Oct., 2002.
5. B. Hoffmann et. al, Abstract W5027, AAPS Annual Meeting Abstracts, Supplement to AAPS Journal Vol 6, Issue S1, October 2004
6. Data on file Hoffmann-La Roche.
7. Chiu Y, Gerber M, Kolis S, Rutman O, Davies B. Effect of rifampicin on the pharmacokinetics of a novel emphysema agent, R667, in healthy men. Presented at the AAPS Annual Meeting, November 2004.
8. Chiu Y, Gerber M, Kolis S, Rutman O, Davies B. Effect of ketoconazole on the pharmacokinetics of a novel emphysema agent, R667, in healthy men. Presented at the ISSX Annual Meeting, August 2004.
9. Brennan B, Brown A, et al. Effect of R667, a novel emphysema agent on the pharmacokinetics of midazolam, in healthy men. Presented at the ACCP Annual Meeting, October 2004.